NU

Nilaben Umeshbhai Gandhi

Active Director Director DIN 09294588
DIN 09294588 First appointment Aug 2021 Primary industry Travel and Hospitality
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Nilaben Umeshbhai Gandhi

Data last updated:

Nilaben Umeshbhai Gandhi is a Director at Hemnil Healthcare Private Limited (since 2021). The company operates in Travel and Hospitality.

DIN 09294588
Primary Designation Director
Industry Travel and Hospitality
First Appointment 26 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hemnil Healthcare Private Limited U85100GJ2021PTC125133
Director26 Aug 20212021Active

Directorship timeline

Open interactive timeline →
Hemnil Healthcare Private Limited
Premium access

Shareholding and investment profile for Nilaben Umeshbhai Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilaben Umeshbhai Gandhi

Nilaben Umeshbhai Gandhi currently holds 1 directorship: Hemnil Healthcare Private Limited (Director, since 26 Aug 2021).

Nilaben Umeshbhai Gandhi was first appointed on 26 Aug 2021 as Director at Hemnil Healthcare Private Limited.

The current boards of Nilaben Umeshbhai Gandhi's companies include Hemali Tejaskumar Gandhi (Hemnil Healthcare Private Limited), Tejaskumar Umeshbhai Gandhi (Hemnil Healthcare Private Limited), Umeshbhai Narayanlal Gandhi (Hemnil Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available